Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

PI Industries offers robust growth opportunities in the high margin segment from the medium- to long-term perspectiveqrcode

Apr. 20, 2020

Favorites Print
Forward
Apr. 20, 2020
PI offers robust growth opportunities in the high margin segment from the medium- to long-term perspective while its debt-free balance sheet offers a high level of comfort, said Haitong. The brokerage is enthused about the company’s diversification into the high growth specialty chemicals business which offers a multi-year growth story.
 
Financials
 
PI Industries Ltd. key Products/Revenue Segments include Active Ingredients which contributed Rs 1920.50 crore to sales value (67.60 per cent of total sales), Formulations which contributed Rs 903.00 crore to sales value (31.78 per cent of total sales), Others which contributed Rs 17.40 crore to sales value (0.61 per cent of total sales)for the year ending March 31, 2019.
 
For the quarter ended December 31, 2019, the company reported consolidated sales of Rs 849.80 crore, down -6.35 per cent from last quarter sales of Rs 907.40 crore and up 20.11 per cent from last year same quarter sales of Rs 707.50 crore. The company reported net profit after tax of Rs 121.20 crore in the latest quarter.
 

Picture 0/1200

More from AgroNews

Magazine

2020 Biologicals Special 2020 Latin America Focus
2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.